| Keep Moving Forward Consulting Llc | |
|
7543 Cranes Creek Ct Winter Park FL 32792-8709 | |
| (813) 922-5289 | |
| Not Available |
| Full Name | Keep Moving Forward Consulting Llc |
|---|---|
| Speciality | Social Worker |
| Location | 7543 Cranes Creek Ct, Winter Park, Florida |
| Authorized Official Name and Position | Nicole O Crawford (OWNER/PROVIDER) |
| Authorized Official Contact | 4078080355 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Keep Moving Forward Consulting Llc 7543 Cranes Creek Ct Winter Park FL 32792-8709 Ph: (813) 922-5289 | Keep Moving Forward Consulting Llc 7543 Cranes Creek Ct Winter Park FL 32792-8709 Ph: (813) 922-5289 |
| NPI Number | 1740068873 |
|---|---|
| Provider Enumeration Date | 09/19/2023 |
| Last Update Date | 09/19/2023 |
| Certification Date | 09/19/2023 |
| Medicare PECOS PAC ID | 7517302136 |
|---|---|
| Medicare Enrollment ID | O20240305001306 |
News Archive
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.
Shire plc has announced that it licensed the North America (U.S. and Canada) rights for the investigational HIV compound, SPD754 (also known as apricitabine), to the Australian biotechnology company Avexa Limited in return for an up-front payment of US$10 million, development and sales related milestones and royalties.
Third-generation cancer immunotherapy, a method of removing cancer using the body's immune system, has shown remarkable clinical benefits in recent years, giving hopes to many researchers and patients.
Probi has signed an agreement giving Ta`am Teva Altman rights to launch Probi's dietary supplement for gut health based on Lp299v™ in Israel. The launch is planned to take place in the second quarter of 2011.
› Verified 9 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740068873 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Provider Name | Nicole O Crawford |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1407298870 PECOS PAC ID: 7719121599 Enrollment ID: I20130917000558 |
News Archive
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.
Shire plc has announced that it licensed the North America (U.S. and Canada) rights for the investigational HIV compound, SPD754 (also known as apricitabine), to the Australian biotechnology company Avexa Limited in return for an up-front payment of US$10 million, development and sales related milestones and royalties.
Third-generation cancer immunotherapy, a method of removing cancer using the body's immune system, has shown remarkable clinical benefits in recent years, giving hopes to many researchers and patients.
Probi has signed an agreement giving Ta`am Teva Altman rights to launch Probi's dietary supplement for gut health based on Lp299v™ in Israel. The launch is planned to take place in the second quarter of 2011.
› Verified 9 days ago
News Archive
Mayo Clinic researchers and their international colleagues have discovered genetic variants that lead to severe arthritis for a subset of women when taking aromatase inhibitors to treat their breast cancer. This serious side effect is so painful that many women halt their lifesaving medication. The findings appear today in the online issue of Journal of Clinical Oncology.
Shire plc has announced that it licensed the North America (U.S. and Canada) rights for the investigational HIV compound, SPD754 (also known as apricitabine), to the Australian biotechnology company Avexa Limited in return for an up-front payment of US$10 million, development and sales related milestones and royalties.
Third-generation cancer immunotherapy, a method of removing cancer using the body's immune system, has shown remarkable clinical benefits in recent years, giving hopes to many researchers and patients.
Probi has signed an agreement giving Ta`am Teva Altman rights to launch Probi's dietary supplement for gut health based on Lp299v™ in Israel. The launch is planned to take place in the second quarter of 2011.
› Verified 9 days ago
Anthropos Fl M H & F T C Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2221 Lee Rd # 21b, Winter Park, FL 32789 Phone: 407-222-4207 | |
Sherry S. Mattos Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1350 N Orange Ave, Suite 296, Winter Park, FL 32789 Phone: 407-579-6009 Fax: 407-622-1200 | |
Vista Psychological Services, Pa Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 120 University Park Dr, Suite 215, Winter Park, FL 32792 Phone: 407-657-5800 Fax: 407-657-4269 | |
David Carter, Psy.d., Pllc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1133 Louisiana Ave, Suite 206, Winter Park, FL 32789 Phone: 407-629-1000 | |
Winter Park Psychology, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 701 W Morse Blvd, Winter Park, FL 32789 Phone: 321-604-7024 | |
Ldr Counseling, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1215 Louisiana Ave, Suite 100, Winter Park, FL 32789 Phone: 407-622-0825 Fax: 407-622-0826 | |
Professional Counseling Sservices Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1950 Lee Rd, Suite 123, Winter Park, FL 32789 Phone: 407-539-3405 Fax: 407-539-0547 |